Results 81 to 90 of about 21,211 (247)

Inflammatory Myocardial Diseases

This book provides a comprehensive review of inflammatory myocardial diseases. It is organized into three sections: (1) Pathobiology of Myocardial Inflammatory Diseases; (2) Imaging for Inflammatory Myocardial Diseases; and (3) Interventions for ...

core   +1 more source

Post-operative left atrial volume index is a predictor of the occurrence of permanent atrial fibrillation after mitral valve surgery in patients who undergo mitral valve surgery

Cardiovascular Ultrasound, 2018
Background Atrial fibrillation (AF) can occur even after the correction of mitral valve (MV) pathology in patients who have pre-operative sinus rhythm and undergo MV surgery.
Min-Kyung Kang, Boyoung Joung, Chi Young Shim, In Jeong Cho, Woo-In Yang, Jeonggeun Moon, Yangsoo Jang, Namsik Chung, Byung-Chul Chang, Jong-Won Ha   +9 more
doaj   +1 more source

Resolution of Refractory Multifocal Atrial Tachycardia in Costello Syndrome Using Trametinib: A Case Supporting MEK Inhibitors as Targeted, Specific Antiarrhythmic

American Journal of Medical Genetics Part A, EarlyView.
ABSTRACT Arrhythmias affect approximately half of patients with Costello syndrome (CS, OMIM # 218040), with non‐reentrant atrial tachycardia being the most common. This case describes an infant with Costello syndrome carrying the pathogenic HRAS c.34G>A (p.G12S) variant who developed early‐onset, drug‐refractory multifocal atrial tachycardia (MAT ...
Vanina Taliercio, Annabelle Wilcox, Stacey Cole, Josue Flores Daboub, José E. Morales Moreno, Kasey G. Andrews, S. Yukiko Asaki, Thomas A. Pilcher, Martin Tristani‐Firouzi, Mary C. Niu, David Viskochil, Benjamin Hammond   +11 more
wiley   +1 more source

Animal models of chronic thromboembolic pulmonary hypertension

Animal Models and Experimental Medicine, EarlyView.
Current animal models of CTEPH. Created using BioRender.com. Abstract Chronic thromboembolic pulmonary hypertension (CTEPH) is a rare, yet life‐threatening disorder characterized by persistent pulmonary vascular obstruction and elevated pulmonary artery pressure, with progressive remodeling and subsequent right heart failure.
Yong‐Jian Zhu, Lin‐Chao Zhou, Xiao‐Xue Zhang, Xiao‐Yang Ren, Yi Yan, Shao‐Fei Liu   +5 more
wiley   +1 more source

Transcatheter Bioprosthetic Aortic Valve Dysfunction:What We Know So Far [PDF]

, 2019
Transcatheter aortic valve replacement (TAVR) is an established alternative to surgical valve replacement for patients with severe aortic stenosis (AS) and increased surgical risk.
Sawaya, Fadi, Sawaya, Fadi J., Jørgensen, Troels H, Jorgensen, Troels Højsgaard, De Backer, Ole, Søndergaard, Lars   +5 more
core   +1 more source

Fimasartan for independent reduction of blood pressure variability in mild-to-moderate hypertension

Drug Design, Development and Therapy, 2016
Mi-Seung Shin,1 Dae Ryong Kang,2 Changsoo Kim,3 Eun Joo Cho,4 Ki-Chul Sung,5 Seok-Min Kang,6 Dong-Soo Kim,7 Seung Jae Joo,8 Seung Hwan Lee,9 Kyung-Kuk Hwang,10 Jeong Bae Park11 1Division of Cardiology, Department of Internal Medicine, Gachon University ...
Shin MS, Kang DR, Kim C, Cho EJ, Sung KC, Kang SM, Kim DS, Joo SJ, Lee SH, Hwang KK, Park JB   +10 more
doaj  

Cardiovascular–Endocrine–Metabolic Medicine: Proposing a New Clinical Sub-Specialty Amid the Cardiometabolic Pandemic

Biomolecules
Cardiovascular–Renal–Hepatic–Metabolic diseases are on the rise worldwide, creating major challenges for patient care and clinical research. Although these conditions share common mechanisms and often respond to similar treatments—such as lifestyle ...
Nikolaos Theodorakis, Maria Nikolaou, Andrew Krentz   +2 more
doaj   +1 more source

Equine models in translational medicine: A comparative approach to human health

Animal Models and Experimental Medicine, EarlyView.
This diagram summarizes and contrasts rodent and equine models, outlining their strengths, limitations, and applications. Horses offer naturally occurring diseases, genetic and physiological similarities to humans, and suitability for longitudinal and clinical‐scale studies.
Shayan Boozarjomehri Amnieh, Katarzyna Ropka‐Molik   +1 more
wiley   +1 more source

Monotherapy with the PCSK9 inhibitor alirocumab versus ezetimibe in patients with hypercholesterolemia:Results of a 24week, double-blind, randomized Phase 3 trial [PDF]

, 2014
Background:Efficacy and safety of alirocumab were compared with ezetimibe in hypercholesterolemic patients at moderate cardiovascular risk not receiving statins or other lipid-lowering therapy. Methods In a Phase 3, randomized, double-blind, double-dummy
Merlet, Laurence, Robinson, Jennifer G., Kastelein, John J.P., Roth, Eli M., Colhoun, Helen M., Pordy, Robert, Taskinen, Marja-Riitta, Ginsberg, Henry N., Kastelein, John J. P., Baccara-Dinet, Marie T.   +9 more
core   +1 more source

The year in cardiovascular medicine 2020: digital health and innovation [Год в сердечно-сосудистой медицине, 2020 г.: цифровое здравоохранение и инновации]

, 2021
Advances in digital health and particularly in artificial intelligence (AI) have led us very close to the true implementation of personalised medicine.
Antoniades, C, Asselbergs, Folkert W, Asselbergs, Fw, Antoniades, Ch, F. W. Asselbergs, Ch. Antoniades, Vardas, P, P. Vardas, Vardas, Panos, Antoniades, Charalambos   +9 more
core   +1 more source